Canada Markets closed

NLS Pharmaceutics AG (NLSP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9288+0.0488 (+5.55%)
At close: 04:00PM EST
0.9480 +0.02 (+2.07%)
After hours: 07:05PM EST
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 37.3500
52 Week Low 30.8210
50-Day Moving Average 31.4174
200-Day Moving Average 32.4913

Share Statistics

Avg Vol (3 month) 33.91M
Avg Vol (10 day) 3511.73k
Shares Outstanding 514.75M
Implied Shares Outstanding 6N/A
Float 87.13M
% Held by Insiders 145.57%
% Held by Institutions 112.22%
Shares Short (Dec. 14, 2021) 4135.42k
Short Ratio (Dec. 14, 2021) 40.06
Short % of Float (Dec. 14, 2021) 41.93%
Short % of Shares Outstanding (Dec. 14, 2021) 40.92%
Shares Short (prior month Nov. 14, 2021) 479.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-80.82%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-6.23M
Diluted EPS (ttm)-0.6910
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.09M
Total Cash Per Share (mrq)0.59
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.91
Book Value Per Share (mrq)0.35

Cash Flow Statement

Operating Cash Flow (ttm)-9.93M
Levered Free Cash Flow (ttm)-7.49M